Congress
$1,001–$15,000
Traded May 15, 2025 · disclosed 25 days later
4 different filers disclosed HUM within 90 days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded May 14, 2025 · Filed May 16, 2025
The CEO of Humana paid $1.5M out of pocket for Humana shares. Shares held went up 27% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$1,496,984
Shares × reported transaction price
$1M+
+27.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals about 9.6% of the CEO's reported total pay for fiscal 2024 ($15.6M)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-03-06. The proxy names this person as CEO for that year. A size comparison, not a judgement
14 days after results of Apr 30, 2025, 77 days before results of Jul 30, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Jul 31, 2024 in the U.S. District Court, D. Delaware. A filing is an allegation, not a finding.
2 such cases were open. Marathe v. Humana Inc., docket 1:24-cv-00898, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −8.4% | −0.6% | −7.8% |
| 30 days | −1.6% | +0.4% | −2.0% |
| 90 days | +16.1% | +8.1% | +8.0% |
| 180 days | −5.3% | +11.9% | −17.3% |
| 365 days | +25.6% | +23.4% | +2.2% |
Past results only. Not a forecast.
Congress
Traded May 15, 2025 · disclosed 25 days later
4 different filers disclosed HUM within 90 days.
Congress
Traded May 30, 2025 · disclosed 7 days later
4 different filers disclosed HUM within 90 days.
Fund moves
20 tracked managers disclosed the same change for Q1 2025. From a 13F filed May 15, 2025 covering holdings at Mar 31, 2025 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.